方盛制药：公司药品生产许可证变更

Core Viewpoint - The company has received a renewed drug production license from the Hunan Provincial Drug Administration, which includes several changes to its production capabilities and license validity [1] Summary by Relevant Sections - License Renewal: The drug production license has been extended until October 16, 2030 [1] - Production Changes: Modifications include changes to the production line for the raw material drug Ezetimibe and the addition of the raw material drug Benidipine to the production scope [1] - Operational Stability: The changes will not affect the company's existing production structure, ensuring stable production capacity [1] - License Number: The new license number is 湘20150028 [1]